CD163 and systemic-onset juvenile idiopathic arthritis: Thornton et al. [30] demonstrated that the hemoglobin scavenger receptor CD163 facilitates regulation and resolution of inflammation and removal of free hemoglobin and is highly expressed in myeloid cells from patients with inflammatory disorders, such as systemic juvenile idiopathic arthritis (SJIA) and macrophage activation syndrome (MAS).